eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

CSL Behring UK Limited

Hayworth House, Market Place, Haywards Heath, West Sussex, RH16 1DB, UK
Telephone: +44 (0)1444 447 400
Fax: +44 (0)1444 447 403
WWW: http://www.cslbehring.co.uk
Medical Information Direct Line: +44 (0)1444 447 405
Medical Information e-mail: medinfo@cslbehring.com
Customer Care direct line: +44 (0)1444 447 402
Out of Hours contact: +44 (0)1444 447 405

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 12/08/2011
PIL Rhophylac 300 (1500 IU)

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 28/07/2010 and displayed until 12/08/2011
Reasons for adding or updating:
  • Addition of separate PILs covering individual presentations
Updated on 12/11/2009 and displayed until 28/07/2010
Reasons for adding or updating:
  • Removal/change of distributor
Updated on 13/06/2008 and displayed until 12/11/2009
Reasons for adding or updating:
  • Company name change or merger
  • Change to date of revision
Updated on 09/11/2006 and displayed until 13/06/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 23/06/2006 and displayed until 09/11/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   human anti-d immunoglobulin